European Companies Search Engine
EU funding (€257,600): Accelerating the development of mating disruptors for disease-transmitting mosquito control Hor17 Jul 2024 EU Research and Innovation programme "Horizon"
Overview
Text
Accelerating the development of mating disruptors for disease-transmitting mosquito control
STOP-MATING aims at building a research and innovation network to advance towards developing novel tools to target the mating behaviour of disease-transmitting mosquitoes for vector control. Challenges related to climate change and insecticide resistance are putting human populations at risk of mosquito-borne diseases. Novel strategies are required to tackle this public health challenge. In STOP-MATING we propose to use the mating systems of disease-transmitting mosquitoes as novel vector control targets. Although disrupting mosquito mating would have a clear impact on mosquito vector numbers, this mechanism is underexploited from a public health perspective. In STOP-MATING we bring together experts from academic and industrial partners with interdisciplinary expertise on bioinformatics, molecular neuroscience, genetic control, behaviour, biophysics, vector ecology and vector control to explore novel vector control approaches. Our objectives are to 1) identify molecular targets for mosquito mating disruption, 2) mutate those targets, 3) analyse associated behavioural effects and 4) explore their potential application into developing mating disruptors and gene drive systems for vector control. We also aim at exploiting the mating behaviour of mosquitoes to develop traps that mimic the environmental stimuli that they respond to during courtship behaviour. STOP-MATING approach is to merge knowledge from laboratory and field researchers to deliver real-world solutions, and to tackle different mosquito species of increasing public health relevance in Europe. Our innovative approaches have the potential to make great impact to reduce the health burden of mosquito-borne diseases.
Funded Companies:
| Company name | Funding amount |
| Imperial College of Science Technology and Medicine | ? |
| Agencia Estatal Consejo Superior de Investigaciones Cientificas | €115,000 |
| BIOGENTS AG | €4,600.00 |
| CARL VON OSSIETZKY UNIVERSITAET OLDENBURG | €41,400 |
| Sequentia Biotech SL | €4,600.00 |
| Universita Degli Studi Di Perugia | €92,000 |
Source: https://cordis.europa.eu/project/id/101183033
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Imperial College of Science Technology and Medicine, London.
The visualizations for "Imperial College of Science Technology and Medicine - EU funding (€257,600): Accelerating the development of mating disruptors for disease-transmitting mosquito control"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
